Phase I Clinical Trials: Key Design and Operational Considerations
Phase I Clinical Trials: Key Design and Operational Considerations Key Design and Operational Considerations in Phase I Clinical Trials Introduction: Why Phase I Trials Are Foundational Phase I clinical trials mark the first time an investigational medicinal product (IMP) is tested in humans. These early-phase studies establish safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), forming…
Read More “Phase I Clinical Trials: Key Design and Operational Considerations” »